Boston Scientific Cash Flow from Operating Activities 2010-2024 | BSX
- Boston Scientific cash flow from operating activities for the quarter ending March 31, 2024 was $0.164B, a 13.68% decline year-over-year.
- Boston Scientific cash flow from operating activities for the twelve months ending March 31, 2024 was $5.061B, a 88.56% increase year-over-year.
- Boston Scientific annual cash flow from operating activities for 2023 was $2.503B, a 64.02% increase from 2022.
- Boston Scientific annual cash flow from operating activities for 2022 was $1.526B, a 18.4% decline from 2021.
- Boston Scientific annual cash flow from operating activities for 2021 was $1.87B, a 24.01% increase from 2020.
Boston Scientific Annual Cash Flow Ops (Millions of US $) |
|
---|---|
2023 | $2,503 |
2022 | $1,526 |
2021 | $1,870 |
2020 | $1,508 |
2019 | $1,836 |
2018 | $310 |
2017 | $1,426 |
2016 | $1,182 |
2015 | $691 |
2014 | $1,269 |
2013 | $1,110 |
2012 | $1,280 |
2011 | $1,008 |
2010 | $325 |
2009 | $835 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $110.032B | $14.240B |
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $176.990B | 23.17 |
Stryker (SYK) | United States | $129.721B | 31.07 |
Medtronic (MDT) | Ireland | $107.023B | 15.47 |
EssilorLuxottica (ESLOY) | France | $100.473B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.064B | 0.00 |
Haleon (HLN) | United Kingdom | $38.264B | 27.93 |
ResMed (RMD) | United States | $30.754B | 28.87 |
Koninklijke Philips (PHG) | Netherlands | $25.408B | 19.68 |
Terumo (TRUMY) | Japan | $25.118B | 35.47 |
Zimmer Biomet Holdings (ZBH) | United States | $23.544B | 15.04 |
Baxter (BAX) | United States | $17.035B | 12.11 |
Insulet (PODD) | United States | $12.323B | 54.64 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.938B | 0.00 |
Demant (WILYY) | Denmark | $10.259B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.044B | 26.31 |
BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
Lantheus Holdings (LNTH) | United States | $5.581B | 13.91 |
GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
Haemonetics (HAE) | United States | $4.304B | 21.27 |
Perrigo (PRGO) | Ireland | $3.758B | 11.39 |
Envista Holdings (NVST) | United States | $3.245B | 13.39 |
Prestige Consumer Healthcare (PBH) | United States | $3.135B | 14.92 |
QuidelOrtho (QDEL) | United States | $2.960B | 16.43 |
Neogen (NEOG) | United States | $2.857B | 27.48 |
TG Therapeutics (TGTX) | United States | $2.610B | 73.43 |
ICU Medical (ICUI) | United States | $2.523B | 22.26 |
Green Thumb Industries (GTBIF) | United States | $2.367B | 46.88 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.240B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $2.131B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.768B | 51.82 |
Warby Parker (WRBY) | United States | $1.729B | 0.00 |
InMode (INMD) | Israel | $1.585B | 8.42 |
Verano Holdings (VRNOF) | United States | $1.463B | 0.00 |
Owens & Minor (OMI) | United States | $1.320B | 11.50 |
AdaptHealth (AHCO) | United States | $1.291B | 9.59 |
National Vision Holdings (EYE) | United States | $1.150B | 36.60 |
AtriCure (ATRC) | United States | $1.059B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.001B | 0.00 |
Evolus (EOLS) | United States | $0.789B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.721B | 15.35 |
Canopy Growth (CGC) | Canada | $0.655B | 0.00 |
Quanterix (QTRX) | United States | $0.625B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.624B | 0.00 |
Valneva SE (VALN) | France | $0.620B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.619B | 14.56 |
PetIQ (PETQ) | United States | $0.612B | 19.78 |
Surmodics (SRDX) | United States | $0.600B | 37.59 |
ZimVie (ZIMV) | United States | $0.452B | 38.49 |
TerrAscend (TSNDF) | Canada | $0.449B | 0.00 |
Jin Medical (ZJYL) | China | $0.425B | 0.00 |
Biote (BTMD) | United States | $0.407B | 9.37 |
OraSure Technologies (OSUR) | United States | $0.348B | 11.19 |
Cerus (CERS) | United States | $0.338B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.335B | 0.00 |
Zynex (ZYXI) | United States | $0.315B | 43.13 |
Viemed Healthcare (VMD) | United States | $0.280B | 27.69 |
MacroGenics (MGNX) | United States | $0.266B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.252B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.92 |
TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
High Tide (HITI) | Canada | $0.197B | 0.00 |
Omeros (OMER) | United States | $0.192B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.177B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
Quipt Home Medical (QIPT) | United States | $0.146B | 0.00 |
Veru (VERU) | United States | $0.141B | 0.00 |
FitLife Brands (FTLF) | United States | $0.141B | 19.98 |
InterCure (INCR) | Israel | $0.134B | 22.61 |
Jushi Holdings (JUSHF) | United States | $0.119B | 0.00 |
Brainsway (BWAY) | Israel | $0.109B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.109B | 0.00 |
Fonar (FONR) | United States | $0.098B | 8.46 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.086B | 0.00 |
MariMed (MRMD) | United States | $0.081B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.072B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
Safety Shot (SHOT) | United States | $0.059B | 0.00 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.044B | 2.90 |
United-Guardian (UG) | United States | $0.043B | 15.45 |
Bright Green (BGXX) | United States | $0.042B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
ImmuCell (ICCC) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Agape ATP (ATPC) | $0.020B | 0.00 | |
Innovative Eyewear (LUCY) | United States | $0.019B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |